Pancreatic Neuroendocrine Tumours

Full Article

MHC Lam, W Cheuk, TK Au Yong, HC Cheng, RKC Ngan

Hong Kong J Radiol 2017;20:292-302

DOI: 10.12809/hkjr1716443

Neuroendocrine tumours (NETs) are a heterogeneous group of malignancies that can arise in different organs. Although NETs account for only 0.5% of all malignancies, their incidence has significantly increased in recent years. In the Asia Pacific region, the most common site of primary NETs is the pancreas. Many new treatment modalities have been shown to be effective in treating NETs. This study reviews the diagnosis, management, and prognosis of pancreatic NETs.


Authors' affiliations:
MHC Lam1, W Cheuk2, TK Au Yong3, HC Cheng1, RKC Ngan1
1Department of Clinical Oncology, Queen Elizabeth Hospital, Jordan, Hong Kong
2Department of Pathology, Queen Elizabeth Hospital, Jordan, Hong Kong
3Department of Nuclear Medicine, Queen Elizabeth Hospital, Jordan, Hong Kong